Skip to main content
Top
Published in: BMC Psychiatry 1/2015

Open Access 01-12-2015 | Research article

Association between suicidal behaviour and impaired glucose metabolism in depressive disorders

Authors: Hannu Koponen, Hannu Kautiainen, Esa Leppänen, Pekka Mäntyselkä, Mauno Vanhala

Published in: BMC Psychiatry | Issue 1/2015

Login to get access

Abstract

Background

Disturbances in lipid metabolism have been linked to suicidal behaviour, but little is known about the association between suicide risk and abnormal glucose metabolism in depression. Hyperglycaemia and hyperinsulinaemia may increase the risk of depression and also the risk for suicide, we therefore studied associations between suicidal behaviour and disturbances in glucose metabolism in depressive patients who had been referred to depression nurse case managers.

Methods

Patients aged 35 years and older (N = 448, mean age 51 years) who were experiencing a new depressive episode, who were referred to depression nurse case managers in 2008–2009 and who scored ≥10 on the Beck Depression Inventory were enrolled in this study. The study was conducted in municipalities within the Central Finland Hospital District (catchment area of 274 000 inhabitants) as part of the Finnish Depression and Metabolic Syndrome in Adults study. The patients’ psychiatric diagnoses and suicidal behaviour were confirmed by the Mini-International Neuropsychiatric Interview. Blood samples, for glucose and lipid determinations, were drawn from participants after 12 h of fasting, which was followed by a 2-hour oral glucose tolerance test (OGTT) when blood was drawn at 0 and 2 h. Insulin resistance was measured by the Quantitative Insulin Sensitivity Check Index (QUICKI) method.

Results

Suicidal ideation (49 %) and previous suicide attempts (16 %) were common in patients with major depressive disorder or dysthymia. Patients with depression and suicidal behaviour had higher blood glucose concentrations at baseline and at 2 hours in the OGTT. Glucose levels associated positively with the prevalence of suicidal behaviour, and the linearity was significant at baseline (p for linearity: 0.012, adjusted for age and sex) and for 2-hour OGTT glucose (p for linearity: 0.004, adjusted for age and sex). QUICKI levels associated with suicidal behavior (p for linearity across tertiles of QUICKI: 0.026). Total and LDL cholesterol and triglyceride levels were also higher in those patients with suicidal behaviour. Multivariate analysis revealed that blood glucose levels, BDI scores and antidepressive medications associated with suicidal behaviour.

Conclusion

Insulin resistance and disturbances in glucose and lipid metabolism may be more common in middle-aged depressive patients with suicidal behaviour.
Literature
1.
go back to reference Ayuso-Mateos JL, Vasquez-Barquero JL, Dowrick C, Lehtinen V, Dalgard OS, Casey P, et al. Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry. 2001;179:308–16.CrossRefPubMed Ayuso-Mateos JL, Vasquez-Barquero JL, Dowrick C, Lehtinen V, Dalgard OS, Casey P, et al. Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry. 2001;179:308–16.CrossRefPubMed
2.
go back to reference Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19.CrossRefPubMed Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19.CrossRefPubMed
3.
go back to reference Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095–105.CrossRefPubMed Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095–105.CrossRefPubMed
4.
go back to reference Isometsä E, Henriksson M, Marttunen M, Heikkinen M, Aro H, Kuoppasalmi K, et al. Mental disorders in young and middle aged men who commit suicide. BMJ. 1995;310:1366–7.CrossRefPubMedPubMedCentral Isometsä E, Henriksson M, Marttunen M, Heikkinen M, Aro H, Kuoppasalmi K, et al. Mental disorders in young and middle aged men who commit suicide. BMJ. 1995;310:1366–7.CrossRefPubMedPubMedCentral
5.
go back to reference Bertolote JM, Fleischman A, De Leo D, Wasserman D. Suicide and mental disorders: do we know enough? Br J Psychiatry. 2003;183:382–3.CrossRefPubMed Bertolote JM, Fleischman A, De Leo D, Wasserman D. Suicide and mental disorders: do we know enough? Br J Psychiatry. 2003;183:382–3.CrossRefPubMed
6.
go back to reference Van Reedt Dortland AKB, Vreeburg SA, Giltay EJ, Licht CMM, Vogelzangs N, van Veen T, et al. The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression. Psychoneuroendocrinology. 2013;38:209–18.CrossRefPubMed Van Reedt Dortland AKB, Vreeburg SA, Giltay EJ, Licht CMM, Vogelzangs N, van Veen T, et al. The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression. Psychoneuroendocrinology. 2013;38:209–18.CrossRefPubMed
7.
go back to reference Ceretta LB, Reus GZ, Abelaira HM, Jordana LK, Schwalm MT, Hoepers NJ, et al. Increased prevalence of mood disorders and suicidal ideation in type 2 diabetic patients. Acta Diabetol. 2012;49 suppl 1:S227–34.CrossRefPubMed Ceretta LB, Reus GZ, Abelaira HM, Jordana LK, Schwalm MT, Hoepers NJ, et al. Increased prevalence of mood disorders and suicidal ideation in type 2 diabetic patients. Acta Diabetol. 2012;49 suppl 1:S227–34.CrossRefPubMed
8.
go back to reference Han SJ, Kim HJ, Choi YJ, Lee KW, Kim DJ. Increased risk of suicidal ideation in Korean adults with both diabetes and depression. Diabetes Res Clin Pract. 2013;101:14–7.CrossRef Han SJ, Kim HJ, Choi YJ, Lee KW, Kim DJ. Increased risk of suicidal ideation in Korean adults with both diabetes and depression. Diabetes Res Clin Pract. 2013;101:14–7.CrossRef
9.
go back to reference Bot M, Pouwer F, de Jonge P, Tack JC, Geelhoed-Duijvestin PHLM, Snoek FJ. Differential associations between depressive symptoms and glycemic control in outpatients with diabetes. Diabet Med. 2013;30:e115–22.CrossRefPubMed Bot M, Pouwer F, de Jonge P, Tack JC, Geelhoed-Duijvestin PHLM, Snoek FJ. Differential associations between depressive symptoms and glycemic control in outpatients with diabetes. Diabet Med. 2013;30:e115–22.CrossRefPubMed
10.
go back to reference Troisi A. Low cholesterol is a risk factor for attentional impulsivity in patients with mood symptoms. Psychiatry Res. 2011;188:83–7.CrossRefPubMed Troisi A. Low cholesterol is a risk factor for attentional impulsivity in patients with mood symptoms. Psychiatry Res. 2011;188:83–7.CrossRefPubMed
11.
go back to reference Stahl SM. Stahl’s Essential Psychopharmacology. Neuroscientific Basis and Practical Applications. 3rd ed. Cambridge, UK: Cambridge University Press; 2008. Stahl SM. Stahl’s Essential Psychopharmacology. Neuroscientific Basis and Practical Applications. 3rd ed. Cambridge, UK: Cambridge University Press; 2008.
12.
go back to reference Muldoon MF, Mackey RH, Korytkowski MT, Flory JD, Pollock BG, Manuck SB. The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers. J Clin Endocrinol Metabolism. 2006;91:718–21.CrossRef Muldoon MF, Mackey RH, Korytkowski MT, Flory JD, Pollock BG, Manuck SB. The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers. J Clin Endocrinol Metabolism. 2006;91:718–21.CrossRef
13.
go back to reference Dunn AJ, Swiergiel AH, de Beaurepaire R. Cytokines as mediators of depression: What can we learn from animal studies? Neurosci Biobehav Rev. 2005;29:891–909.CrossRefPubMed Dunn AJ, Swiergiel AH, de Beaurepaire R. Cytokines as mediators of depression: What can we learn from animal studies? Neurosci Biobehav Rev. 2005;29:891–909.CrossRefPubMed
14.
go back to reference Christmas DM, Potocar JP, Davies SJC. A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase. Neuropsychiatr Dis Treat. 2011;7:431–9.PubMedPubMedCentral Christmas DM, Potocar JP, Davies SJC. A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase. Neuropsychiatr Dis Treat. 2011;7:431–9.PubMedPubMedCentral
15.
go back to reference Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Progr Neuro-Psychopharmacol Biol Psychiatry. 2011;35:664–75.CrossRef Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Progr Neuro-Psychopharmacol Biol Psychiatry. 2011;35:664–75.CrossRef
16.
go back to reference Maes M, Ringel K, Kubera M, Berk M, Rybakowski J. Increased autoimmune activity against 5-HT: A key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression. J Affect Disord. 2012;136:386–92.CrossRefPubMed Maes M, Ringel K, Kubera M, Berk M, Rybakowski J. Increased autoimmune activity against 5-HT: A key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression. J Affect Disord. 2012;136:386–92.CrossRefPubMed
17.
go back to reference Banerjee M, Saxena M. Interleukin-1 (IL-1) family of cytokines: Role in Type 2 diabetes. Clinica Chimica Acta. 2012;413:1163–70.CrossRef Banerjee M, Saxena M. Interleukin-1 (IL-1) family of cytokines: Role in Type 2 diabetes. Clinica Chimica Acta. 2012;413:1163–70.CrossRef
18.
go back to reference Silic A, Karlovic D, Serretti A. Increased inflammation and lower platelet 5-HT in depression with metabolic syndrome. J Affect Disord. 2012;141:72–8.CrossRefPubMed Silic A, Karlovic D, Serretti A. Increased inflammation and lower platelet 5-HT in depression with metabolic syndrome. J Affect Disord. 2012;141:72–8.CrossRefPubMed
19.
go back to reference Valkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and depression: Asystematic review and meta-analysis of longitudinal studies. J Affect Disord. 2013;150:736–44.CrossRefPubMed Valkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and depression: Asystematic review and meta-analysis of longitudinal studies. J Affect Disord. 2013;150:736–44.CrossRefPubMed
20.
go back to reference Serafini G, Pompili M, Seretti ME, Stefani H, Palermo M, Coryell W, et al. The role of imflammatory cytokines in suicidal behavior: A systematic review. European Neuropsychopharmacol. 2013;23:1672–86.CrossRef Serafini G, Pompili M, Seretti ME, Stefani H, Palermo M, Coryell W, et al. The role of imflammatory cytokines in suicidal behavior: A systematic review. European Neuropsychopharmacol. 2013;23:1672–86.CrossRef
21.
go back to reference Kan C, Silv N, Golden SH, Rajala U, Timonen M, Stahl D, et al. A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care. 2013;36:480–9.CrossRefPubMedPubMedCentral Kan C, Silv N, Golden SH, Rajala U, Timonen M, Stahl D, et al. A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care. 2013;36:480–9.CrossRefPubMedPubMedCentral
22.
go back to reference Akbaraly TN, Kumari M, Head J, Ritchie K, Ancelin M-L, Tabak AG, et al. Glycemia, insulin resistance, insulin secretion, and risk of depressive symptoms in middle age. Diabetes Care. 2013;36:928–34.CrossRefPubMedPubMedCentral Akbaraly TN, Kumari M, Head J, Ritchie K, Ancelin M-L, Tabak AG, et al. Glycemia, insulin resistance, insulin secretion, and risk of depressive symptoms in middle age. Diabetes Care. 2013;36:928–34.CrossRefPubMedPubMedCentral
23.
go back to reference Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.CrossRefPubMed Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.CrossRefPubMed
24.
go back to reference Sheehan DV, Lecrubier Y. Mini-International Neuropsychiatric Interview (MINI). Tampa, FL: University of South Florida, Institute for Research in Psychiatry; 1994. Paris: INSERM-Hopital de la Salpetriere. Sheehan DV, Lecrubier Y. Mini-International Neuropsychiatric Interview (MINI). Tampa, FL: University of South Florida, Institute for Research in Psychiatry; 1994. Paris: INSERM-Hopital de la Salpetriere.
25.
go back to reference Katz A, Nambi SS, Mather K, Baron AD, Follman DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrin Metab. 2000;85:2402–10.CrossRef Katz A, Nambi SS, Mather K, Baron AD, Follman DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrin Metab. 2000;85:2402–10.CrossRef
26.
go back to reference Sokero PT, Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Isometsä ET. Suicidal ideation and attempts among psychiatric patients with major depressive disorder. J Clin Psychiatry. 2003;64:1094–100.CrossRefPubMed Sokero PT, Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Isometsä ET. Suicidal ideation and attempts among psychiatric patients with major depressive disorder. J Clin Psychiatry. 2003;64:1094–100.CrossRefPubMed
27.
go back to reference Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJM, et al. Statins and the risk of incident diabetes: a collaborative meta-analysis of randomized statin trials. Lancet. 2010;375:735–42.CrossRefPubMed Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJM, et al. Statins and the risk of incident diabetes: a collaborative meta-analysis of randomized statin trials. Lancet. 2010;375:735–42.CrossRefPubMed
28.
go back to reference Mather AA, Cox BJ, Enns MW, Sareen J. Associations of obesity with psychiatric disorders and suicidal behaviors in a nationally representative sample. J Psychosom Res. 2009;66:277–85.CrossRefPubMed Mather AA, Cox BJ, Enns MW, Sareen J. Associations of obesity with psychiatric disorders and suicidal behaviors in a nationally representative sample. J Psychosom Res. 2009;66:277–85.CrossRefPubMed
29.
go back to reference Kressel G, Trunz B, Bub A, Hülsman O, Wolters M, Lichtinghagen R, et al. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. Athetosclerosis. 2009;202:263–71.CrossRef Kressel G, Trunz B, Bub A, Hülsman O, Wolters M, Lichtinghagen R, et al. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. Athetosclerosis. 2009;202:263–71.CrossRef
30.
go back to reference Sublette ME, Galfalvy HC, Fuchs D, Lapidus M, Grunebaum MF, Oquendo MA, et al. Plasma kynurine levels are elevated in suicide attempters with major disorder. Brain Behav Immun. 2011;25:1272–8.CrossRefPubMedPubMedCentral Sublette ME, Galfalvy HC, Fuchs D, Lapidus M, Grunebaum MF, Oquendo MA, et al. Plasma kynurine levels are elevated in suicide attempters with major disorder. Brain Behav Immun. 2011;25:1272–8.CrossRefPubMedPubMedCentral
31.
go back to reference Suokas JT, Perälä J, Suominen K, Saari S, Lönnqvist J, Suvisaari JM. Epidemiology of suicide attempts among persons with psychotic disorder in the general population. Schizophrenia Res. 2010;124:22–8.CrossRef Suokas JT, Perälä J, Suominen K, Saari S, Lönnqvist J, Suvisaari JM. Epidemiology of suicide attempts among persons with psychotic disorder in the general population. Schizophrenia Res. 2010;124:22–8.CrossRef
32.
go back to reference Mäntyselkä P, Korniloff K, Saaristo T, Koponen H, Eriksson J, Puolijoki H, et al. Association of depressive symptoms with impaired glucose regulation, screen-detected and previously known type 2 diabetes – findings from the Finnish D2D survey. Diabetes Care. 2011;34:71–6.CrossRefPubMed Mäntyselkä P, Korniloff K, Saaristo T, Koponen H, Eriksson J, Puolijoki H, et al. Association of depressive symptoms with impaired glucose regulation, screen-detected and previously known type 2 diabetes – findings from the Finnish D2D survey. Diabetes Care. 2011;34:71–6.CrossRefPubMed
33.
go back to reference Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research. Psychosomatic Med. 2011;73:114–26.CrossRef Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research. Psychosomatic Med. 2011;73:114–26.CrossRef
34.
go back to reference Belvedere Murri R, Pariante C, Mondelli V, Masotti M, Atti AR, Mellacqua Z, et al. HPA axis and aging in depression: Systematic review and meta-analysis. Psychoneuroendocrinology. 2014;41:46–62.CrossRef Belvedere Murri R, Pariante C, Mondelli V, Masotti M, Atti AR, Mellacqua Z, et al. HPA axis and aging in depression: Systematic review and meta-analysis. Psychoneuroendocrinology. 2014;41:46–62.CrossRef
35.
go back to reference Malone KM, Waternaux C, Haas GL, Cooper TB, Li S, Mann JJ. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. Am J Psychiatry. 2003;160:773–9.CrossRefPubMed Malone KM, Waternaux C, Haas GL, Cooper TB, Li S, Mann JJ. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. Am J Psychiatry. 2003;160:773–9.CrossRefPubMed
36.
go back to reference Olie E, Picot MC, Guillaume S, Abbar M, Courtet P. Measurement of total serum cholesterol in the evaluation of suicidal risk. J Affect Disord. 2011;133:234–8.CrossRefPubMed Olie E, Picot MC, Guillaume S, Abbar M, Courtet P. Measurement of total serum cholesterol in the evaluation of suicidal risk. J Affect Disord. 2011;133:234–8.CrossRefPubMed
37.
go back to reference Tedders SH, Fokong KD, McKenzie LE, Wesley C, Yu L, Zhang J. Low cholesterol is associated with depression among US household population. J Affect Disord. 2011;135:115–21. 51: 1060–1063.CrossRefPubMed Tedders SH, Fokong KD, McKenzie LE, Wesley C, Yu L, Zhang J. Low cholesterol is associated with depression among US household population. J Affect Disord. 2011;135:115–21. 51: 1060–1063.CrossRefPubMed
38.
go back to reference Tanskanen A, Vartiainen E, Tuomilehto J, Viinamäki H, Lehtonen J, Puska P. High serum cholesterol and risk of suicide. Am J Psychiatry. 2000;157:648–50.CrossRefPubMed Tanskanen A, Vartiainen E, Tuomilehto J, Viinamäki H, Lehtonen J, Puska P. High serum cholesterol and risk of suicide. Am J Psychiatry. 2000;157:648–50.CrossRefPubMed
39.
go back to reference Mather KJ, Hunt AE, Steinberg HO, Paradisi G, Hook G, Katz A, et al. Repeatability characteristics of simple indices of insulin resistance: Implications for research applications. J Clin Endocrinol Metabolism. 2001;86:5457–64.CrossRef Mather KJ, Hunt AE, Steinberg HO, Paradisi G, Hook G, Katz A, et al. Repeatability characteristics of simple indices of insulin resistance: Implications for research applications. J Clin Endocrinol Metabolism. 2001;86:5457–64.CrossRef
Metadata
Title
Association between suicidal behaviour and impaired glucose metabolism in depressive disorders
Authors
Hannu Koponen
Hannu Kautiainen
Esa Leppänen
Pekka Mäntyselkä
Mauno Vanhala
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2015
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-015-0567-x

Other articles of this Issue 1/2015

BMC Psychiatry 1/2015 Go to the issue